182 related articles for article (PubMed ID: 32585080)
61. Diagnostic accuracy of midkine on hepatocellular carcinoma: A meta-analysis.
Zhang BH; Li B; Kong LX; Yan LN; Yang JY
PLoS One; 2019; 14(10):e0223514. PubMed ID: 31600291
[TBL] [Abstract][Full Text] [Related]
62. Preoperative plasma growth-differentiation factor-15 for prediction of acute kidney injury in patients undergoing cardiac surgery.
Heringlake M; Charitos EI; Erber K; Berggreen AE; Heinze H; Paarmann H
Crit Care; 2016 Oct; 20(1):317. PubMed ID: 27717384
[TBL] [Abstract][Full Text] [Related]
63. A meta-analysis on the diagnostic value of diffusion-weighted imaging on ovarian cancer.
Dai G; Liang K; Xiao Z; Yang Q; Yang S
J BUON; 2019; 24(6):2333-2340. PubMed ID: 31983103
[TBL] [Abstract][Full Text] [Related]
64. The Diagnostic Accuracy of PET(CT) in Patients With Neuroblastoma: A Meta-Analysis and Systematic Review.
Li HF; Mao HJ; Zhao L; Guo DL; Chen B; Yang JF
J Comput Assist Tomogr; 2020; 44(1):111-117. PubMed ID: 31939891
[TBL] [Abstract][Full Text] [Related]
65. Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia).
Salehi MH; Kamalidehghan B; Houshmand M; Aryani O; Sadeghizadeh M; Mossalaeie MM
Mol Biol Rep; 2013 Nov; 40(11):6495-9. PubMed ID: 24078096
[TBL] [Abstract][Full Text] [Related]
66. DIAGNOSTIC VALUE OF ANTI-MÜLLERIAN HORMONE AS A BIOMARKER FOR POLYCYSTIC OVARY SYNDROME: A META-ANALYSIS UPDATE.
Zhao Y; Zhao Y; Wang C; Liang Z; Liu X
Endocr Pract; 2019 Oct; 25(10):1056-1066. PubMed ID: 31414908
[No Abstract] [Full Text] [Related]
67. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
[TBL] [Abstract][Full Text] [Related]
68. Pepsin in Saliva as a Diagnostic Marker for Gastroesophageal Reflux Disease: A Meta-Analysis.
Guo Z; Wu H; Jiang J; Zhang C
Med Sci Monit; 2018 Dec; 24():9509-9516. PubMed ID: 30596632
[TBL] [Abstract][Full Text] [Related]
69. The diagnostic accuracy of direct agglutination test for serodiagnosis of human visceral leishmaniasis: a systematic review with meta-analysis.
Mohebali M; Keshavarz H; Shirmohammad S; Akhoundi B; Borjian A; Hassanpour G; Mamishi S; Mahmoudi S
BMC Infect Dis; 2020 Dec; 20(1):946. PubMed ID: 33308170
[TBL] [Abstract][Full Text] [Related]
70. Diagnostic performance of interferon-gamma release assay for diagnosis of tuberculous pericarditis: A meta-analysis.
Seo HT; Kim YS; Ock HS; Kang LH; Byun KS; Jeon DS; Kim SJ
Int J Clin Pract; 2020 May; 74(5):e13479. PubMed ID: 31927772
[TBL] [Abstract][Full Text] [Related]
71. Can procalcitonin be used to diagnose Gram-negative bloodstream infection? Evidence based on a meta-analysis.
He C; Wang B; Wang YF; Shen YC
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3253-3261. PubMed ID: 28770957
[TBL] [Abstract][Full Text] [Related]
72. Diagnostic Performance of F-18 Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for Differentiation of Benign and Malignant Vertebral Compression Fractures: A Meta-Analysis.
Kim SJ; Lee JS
World Neurosurg; 2020 May; 137():e626-e633. PubMed ID: 32105873
[TBL] [Abstract][Full Text] [Related]
73. Diagnostic accuracy of tumor necrosis factor-alpha assay for tuberculous pleurisy: A PRISMA-compliant meta-analysis.
Li M; Luo Z; Zhu W; Khan RSU; Ummair SU; Shi S
Medicine (Baltimore); 2016 Nov; 95(48):e5510. PubMed ID: 27902616
[TBL] [Abstract][Full Text] [Related]
74. Is neutrophil CD11b a special marker for the early diagnosis of sepsis in neonates? A systematic review and meta-analysis.
Qiu X; Li J; Yang X; Tang J; Shi J; Tong Y; Qu Y; Mu D
BMJ Open; 2019 May; 9(4):e025222. PubMed ID: 31048432
[TBL] [Abstract][Full Text] [Related]
75. Serum FGF-21, GDF-15, and blood mtDNA copy number are not biomarkers of Parkinson disease.
Davis RL; Wong SL; Carling PJ; Payne T; Sue CM; Bandmann O
Neurol Clin Pract; 2020 Feb; 10(1):40-46. PubMed ID: 32190419
[TBL] [Abstract][Full Text] [Related]
76. Biomarkers of mitochondrial disorders.
Shayota BJ
Neurotherapeutics; 2024 Jan; 21(1):e00325. PubMed ID: 38295557
[TBL] [Abstract][Full Text] [Related]
77. Diagnostic utility of GDF15 in neurodegenerative diseases: A systematic review and meta-analysis.
Xue XH; Tao LL; Su DQ; Guo CJ; Liu H
Brain Behav; 2022 Feb; 12(2):e2502. PubMed ID: 35068064
[TBL] [Abstract][Full Text] [Related]
78. A new diagnostic indication device of a biomarker growth differentiation factor 15 for mitochondrial diseases: From laboratory to automated inspection.
Koga Y; Povalko N; Inoue E; Ishii A; Fujii K; Fujii T; Murayama K; Mogami Y; Hata I; Ikawa M; Fukami K; Fukumoto Y; Nomura M; Ichikawa K; Yoshida K
J Inherit Metab Dis; 2021 Mar; 44(2):358-366. PubMed ID: 32965044
[TBL] [Abstract][Full Text] [Related]
79. Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletions.
Formichi P; Cardone N; Taglia I; Cardaioli E; Salvatore S; Gerfo AL; Simoncini C; Montano V; Siciliano G; Mancuso M; Malandrini A; Federico A; Dotti MT
Neurol Sci; 2020 Dec; 41(12):3653-3662. PubMed ID: 32504279
[TBL] [Abstract][Full Text] [Related]
80. Growth Differentiation Factor-15 Is Considered a Predictive Biomarker of Long COVID in Non-hospitalized Patients.
Ono R; Takayama S; Abe M; Arita R; Abe T; Ishii T
Cureus; 2024 May; 16(5):e59433. PubMed ID: 38826986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
